Intracorporeal marker and marker delivery device

• US 8,498,693 B2
• Filed: 04/08/2011
• Issued: 07/30/2013
• Est. Priority Date: 02/02/1999
• Status: Expired due to Fees

• Current Assignee: Senorx Incorporated (Becton, Dickinson & Co)
• Original Assignee: Senorx Incorporated (Becton, Dickinson & Co)
• Inventors: Jones, Michael L., Lubock, Paul, Merritt, John
• Primary Examiner(s): Luong, Peter
• Application Number:
  US13/082,463
• Publication Number:
  US 20110184280A1
• Time in Patent Office: 844 Days
• Field of Search: 604/07, 604/14, 604/20, 604/24, 604/26, 604/31, 604/37, 600/407, 600/414, 600/420, 600/424, 600/426, 600/431, 600/437
• US Class Current: 600/431
• CPC Class Codes: A61B 17/0057 Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect sutures A61B17/04; closing rectum or urethra near body surface A61F2/0009
• CPC Class Codes: A61B 2017/00637 for sealing trocar wounds through abdominal wall
• CPC Class Codes: A61B 2017/00898 expandable upon contact with fluid
• CPC Class Codes: A61B 2090/3908 Soft tissue, e.g. breast tissue
• CPC Class Codes: A61B 2090/3925 ultrasonic
• CPC Class Codes: A61B 2090/3987 Applicators for implanting markers
• CPC Class Codes: A61B 90/39 Markers, e.g. radio-opaque or breast lesions markers

Abstract

An elongated intracorporeal remotely detectable marker includes a core of bioabsorbable fibers. An outer jacket of bioabsorbable fibers is disposed around at least part of the core. In one embodiment, for example, the core has a longitudinal extent and a pair of opposed ends, and the outer jacket is disposed around the longitudinal extent of the core, with the pair of opposed ends being exposed.

Claims

1. A remotely detectable elongated intracorporeal marker, comprising:

a core of bioabsorbable fibers; and

an outer jacket of bioabsorbable fibers disposed around at least part of the core.

2. The intracorporeal marker of claim 1, wherein the core has a longitudinal extent and a pair of opposed ends, and the outer jacket is disposed around the longitudinal extent of the core and with the pair of opposed ends being exposed.

3. The intracorporeal marker of claim 1, further comprising a radiopaque marker element disposed around the outer jacket.

4. The intracorporeal marker of claim 1, wherein the bioabsorbable fibers of the core comprise at least one material selected from the group consisting of cellulose, polylactic acid, a copolymer of polylactic acid and glycolic acid, and polycaprolactone.

5. The intracorporeal marker of claim 4, wherein the cellulose is oxidized, regenerated cellulose.

6. The intracorporeal marker of claim 1, wherein the outer jacket is at least in part woven fabric.

7. The intracorporeal marker of claim 1, wherein the marker is in a compressed condition, and maintained in the compressed condition by having incorporated therein a binding agent.

8. The intracorporeal marker of claim 7, wherein the binding agent is at least one water soluble polymer selected from the group consisting of polyvinyl alcohol, polyethylene glycol and polyvinyl pyrollidone.

9. The intracorporeal marker of claim 1, comprising at least one bioactive component selected from the group consisting of therapeutic and diagnostic agents incorporated therein.

10. The intracorporeal marker of claim 1, wherein the core includes a material selected from the group consisting of polylactic acid, a co-polymer of polylactic acid and glycolic acid, polycaprolactone, collagen and mixtures thereof, including mixtures with an oxidized cellulose.

11. The intracorporeal marker of claim 1, comprising a radiopaque marker element disposed around a central portion of the outer jacket.

12. The intracorporeal marker of claim 11, wherein the radiopaque marker element holds the central portion to restrict expansion thereof.

13. The intracorporeal marker of claim 12, wherein the outer jacket is configured to expand into a bow-tie shape when exposed to body fluid or other water based fluid.

14. The intracorporeal marker of claim 1 which has been compressed at least 25%, and is bound in a compressed bound condition by a polymer binding agent selected from the group of water soluble polymers consisting of polyvinyl alcohol, polyethylene glycol and polyvinyl pyrollidone.

15. The intracorporeal marker of claim 1, which is about 0.5 mm to about 12 mm in diameter and about 5 to about 30 mm in length.

16. The intracorporeal marker of claim 1, wherein the bioabsorbable fibers of the outer jacket comprise at least one material selected from the group consisting of oxidized cellulose, oxidized regenerated cellulose, polylactic acid, a copolymer of polylactic acid and glycolic acid, and polycaprolactone.

17. A remotely imageable marker system for an intracorporeal site, comprising:

a first tissue marker pellet comprised of a polysaccharide, the polysaccharide exhibiting hemostatic properties; and

a second tissue marker for delivery to a patient site with the first tissue marker pellet, the second tissue marker configured as a fibrous marker comprising;

a core of bioabsorbable fibers; and

an outer jacket of bioabsorbable fibers disposed around at least part of the core.